Citius Pharmaceuticals, Inc.: 10-Q filed 2016-08-15
What Citius Pharmaceuticals, Inc. reported in its quarterly report filed 2016-08-15 (fiscal Q3 2016): 28 published measures, 72 facts as tagged in accession 0001477932-16-011894.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-08-15
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001477932-16-011894 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Citius Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 23,013,945 | USD | |
| At 2015-09-30 | 741,538 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 18,160,213 | USD | |
| At 2015-09-30 | -635,213 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 1,626,140 | USD | |
| At 2015-09-30 | 676,137 | USD | |
| At 2015-06-30 | 950,997 | USD | |
| At 2014-09-30 | 1,552,060 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -3,615,929 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -5,706,104 | USD | 274 |
| 2015-04-01 to 2015-06-30 | -824,972 | USD | 91 |
| 2014-10-01 to 2015-06-30 | -1,993,948 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | -4,133,433 | USD | 274 |
| 2014-10-01 to 2015-06-30 | -1,680,116 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | 4,827,688 | USD | 274 |
| 2014-10-01 to 2015-06-30 | 1,079,053 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | 255,748 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -14,746,653 | USD | |
| At 2015-09-30 | -9,040,549 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 4,414 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 280,764 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 517,677 | USD | 274 |
| 2015-04-01 to 2015-06-30 | 163,547 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 381,076 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -2,126,434 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -4,042,721 | USD | 274 |
| 2015-04-01 to 2015-06-30 | -773,729 | USD | 91 |
| 2014-10-01 to 2015-06-30 | -2,261,548 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 2,020,568 | USD | |
| At 2015-09-30 | 736,137 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 4,445 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 4,445 | USD | 274 |
| 2014-10-01 to 2015-06-30 | 7,500 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 4,853,732 | USD | |
| At 2015-09-30 | 1,376,751 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 309,174 | USD | |
| At 2015-09-30 | 559,150 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 1,586,796 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 2,126,434 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 4,042,721 | USD | 274 |
| 2015-04-01 to 2015-06-30 | 773,729 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 2,261,548 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 381,119 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 1,009,975 | USD | 274 |
| 2015-04-01 to 2015-06-30 | 415,531 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 1,174,892 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 73,038,060 | shares | |
| At 2015-09-30 | 34,117,886 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 32,833,828 | USD | |
| At 2015-09-30 | 8,371,218 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 4,108 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 585,028 | USD | |
| At 2015-09-30 | 8,260 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -3,615,929 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -5,706,104 | USD | 274 |
| 2015-04-01 to 2015-06-30 | -824,972 | USD | 91 |
| 2014-10-01 to 2015-06-30 | -1,993,948 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 1,464,551 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 2,515,069 | USD | 274 |
| 2015-04-01 to 2015-06-30 | 194,651 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 705,580 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | 671 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 93,000 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 367,000 | USD | 274 |
| 2015-04-01 to 2015-06-30 | 87,000 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 261,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -1,489,495 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -1,663,383 | USD | 274 |
| 2015-04-01 to 2015-06-30 | -51,243 | USD | 91 |
| 2014-10-01 to 2015-06-30 | 267,600 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | -494,752 | USD | 274 |
| 2014-10-01 to 2015-06-30 | 228,168 | USD | 273 |
Inspect the source
- Entity
- Citius Pharmaceuticals, Inc. / CIK 0001506251
- Captured
- 2026-09-20T09:12:24.553Z
- SEC response SHA-256
dab437b1abcb106ce657672edecf4aab637b5713b2c1870820e246433043b176
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001506251.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))